Researchers are working on a redesigned pump that could offer hope for those with HFpEF, which accounts for about 32 million heart failure cases globally.

If this new pump proves successful in clinical testing, it could revolutionize heart failure treatment, offering renewed ...

The combination therapy improved LVEF, quality of life, clinical outcomes, and more, but implementation questions remain.

Astronomers have for the first time detected a coronal mass ejection from another star, shedding light on worlds orbiting red ...

Q3 2025 Earnings Call November 12, 2025 4:30 PM ESTCompany ParticipantsMiranda Peto BenvenutiPeter Altman - CEO, President ...

The study, which was simultaneously published in Circulation and presented as a Late-Breaking Clinical Trial at the American Heart Association Scientific Sessions, marked a significant step toward ...

The answer is very clear that if you have MI and preserved EF, there is no benefit of using a beta-blocker. Sripal Bangalore ...

For the first time, astronomers have detected a massive eruption — severe enough to devastate the atmosphere of a nearby ...

A boxed warning now lies at the top of the phase III study, PREVENT-TAHA8, which had reported that an intracoronary infusion ...

Background Acute decompensated heart failure (ADHF) with reduced ejection fraction often requires inotropic support. While dobutamine is commonly used, its safety and efficacy remain debated.

NEW ORLEANS -- A polypill that combines three of the four mainstays of treatment for heart failure with reduced ejection ...

Trastuzumab emtansine is linked to a lower incidence of decrease in left ventricular ejection fraction than other trastuzumab ...